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Severe asymptomatic aortic valve stenosis.
Value of the recently proposed parameters: deformation imaging,
exercise and ventriculo arterial impedance.
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Background:  Ventriculo-arterial impedance (ZVA) and Exercise echocar-
diography are new parameters proposed to best characterize patients with
aortic valve stenosis (AS).
Purpose: we sought to compare the independent value of these new indices.
Methods: we analyzed these new indices in a large prospective series of
207 consecutive patients followed for a severe asymptomatic AS.
Results: The correlations between conventional indices of aortic valve
severity, ZVA, and exercise stress echocardiography results were weak. We,
then, can  distinguish 4 distinct categories of AS patients according to ZVA
and according to the result of the exercise stress echocardiography (figure). 
Conclusion: ZVA as well as Exercise echocardiography can help but have
limitations in the decision making in regard to the management of severe
asymptomatic AS. Nevertheless, the decision to operate or not a supposed
asymptomatic patient is still multiparametric.
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Purpose: Femoral transcatheter aortic valve implantation (TAVI) is usually
done by surgical cut down under general anesthesia. Complete percutaneous
approach has become widely accepted in endovascular management of aortic
disease, and we have decided to apply this technique for TAVI. We aimed to
evaluate the impact of the sheath size on safety and efficacy of this technique.
Method:The study cohort included 64 consecutive patients who underwent
femoral approach using Prostar XL device at our institution between Mar 2008
and Feb 2010. The cohort was divided into two groups: group 1, 18 or 19 Fr
sheath (1 Prostar XL device) and group 2, 22 or 24Fr (2 Prostar XL). The iliac
and femoral angiogram was obtained before insertion and after removal of the
sheath using contralateral approach. Device success was defined as immediate
hemostasis without surgery or death related to access site during hospital stay.
Results: Clinical characteristics were similar in both groups (83.6±5.7
years, male gender 50% and logistic Euroscore 25.3±11.0%) besides higher
rate of hypertension (81.0% vs 56.1%; p=0.03) in group 1.
In group 1, Corevalve was used in 14 cases and Edwards valve in 9 cases. In
group 2, 22 Fr sheath was used in 22 cases and 24Fr in 19. 
The angiogram showed smaller femoral artery diameter in group 1 (7.7±1.2 vs
9.0±0.9mm; p=0.001 and common iliac artery 9.4±1.4 vs 11.5±1.8mm;
p=0.001), a lower calcium score (0.6±0.8 vs 1.1±0.7; p=0.034) and tortuosity
score (0.6±0.7 vs 1.2±0.7; p=0.001). Device success was achieved in 100% in
group 1 and 95.1% in group 2 (p=ns).The rate of iliac artery perforation or
rupture was lower in group 1 (0% vs 9.8%; p=0.044). Death due to access site
complication was observed only in 1 case in group 2 (p=ns).
Conclusion: Thanks to the development of lower profile devices, percuta-
neous approach for femoral arterial access is emerging as a promising method
for TAVI and will decrease the need for general anesthesia in this high risk
patients.
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The cardiac abscess formation is appraised to 20-30% during the infectious
endocarditis (IE). It is more frequent during prosthesis endocarditis and it can
reach 60%. The prognosis is generally reserved . Objective To determine
echocardiographic, bacteriological and evolutive features of prothetic IE com-
plicated of abscess.  
Retrospective study including 51 patients having certain or probable IE
according to Duke criterias between 2002 and 2005. At 9 patients (17,64%)
the endocarditis was complicated of prothetic abscess. It was about 6 men and
3 women with a middle age of 39 ±years. IE was  la ate IE in 5 cases. . Clin-
ical and biological infectious syndrome was constant. Isolated germs were sta-
phylococcus aureus in 2 cases, GRAM négatif Bacillus in 2 cases. Culture
negative endocarditis were noted in 5 cases. Brucellosis serology was positive
at one patient. Prothetic abcess was diagnosed by transthoracic echocardio-
graphy (TTE) at 2 patients and by transesophagal echocardiography (TEE) at
all patients. 
The abcess was localized on the aortic prosthesis at 5 patients, mitral pro-
thesis at 3 patients and mitroaortic prothesis at one patient. TEE identified
annular abcess at 2 patients and a myocardial abcess at 1 patient. Secondary
septic localizations were noted at 6 patients: 4 cerebral abscesses, 2 splenic
localization, a renal localization and an articular localization. High degree atri-
oventricular blocks were observed at 3 patients. The recourse to the surgery
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PABV 
(n=23)
PABV alone 
(n=18)
Primary TAVI
or AVR
(n=140)
Medical 
treatment 
(n=72)
Age (years) 79±8 83±8 82±8 83±9
EuroSCORE 
(%)
35±21 39±24 25±12 31±17
Hospital 
survival (%)
100 67 88 86
One-year 
survival (%)
94±5 33±11 74±4 30±6
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N=76 N=79
N=29 N=23
EX
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Syst BP 146±21
ZVA 7.8±24
Ex ZVA 4.7±1.9
LV EF 59±10
AEA 0.9±0.2
Mean PG 42±14
Ex Mean OG 68±8
LA area 18.6±5.8
E/e´ 9.5±2.9
Ex E/e´11.3±6.2
Radial 2DS 34±17
Circum f 2DS -14.8±5.6
Long 2DS -15±3 
Syst BP 144±20
ZVA 7.0±1.6
Ex ZVA 5.1±2.3
LV EF 67±8
AEA 0.8±0.2
Mean PG 48±17
Ex Mean OG 51±19
LA area 19±5.1
E/e´11.7±5.2
Ex E/e´14±7.7
Radial 2DS 33±12
Circum f 2DS -14±4
Long 2DS -16±5
Syst BP 142±20
ZVA 4.0±0.7
Ex ZVA 4.4±1.6
LV EF 68±8
AEA 0.9±0.2
Mean PG 42±14
Ex Mean G 51±18
LA 22±5.7
E/e´11±3
Ex E/e´11±5
Radial 2DS 28±7
Circum f 2DS -13±5
Long 2DS -15±3
Syst BP 139±16
ZVA 4.2±0.6
Ex ZVA 4±1.2
LV EF 61±9
AEA 0.9±0.2
Mean PG 45±18
Ex Mean PG 62±8
LA Area 20±10
E/e´11±3
Ex E/e´11±5
Radial 2DS 28±7
Circum f 2DS -13±4.5
Long 2DS -15±3 
Characteristics of the patients
